VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.

about

Lipopolysaccharide Effect on Vascular Endothelial Factor and Matrix Metalloproteinases in Leukemic Cell Lines In vitro.A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies Antisense therapeutics in oncology: current status.

P2860

Q36088849-AF910146-C538-4C99-9871-D381B9396FD5 Q36414254-603C8E78-92E3-48EB-AE1F-D70DCFD03E28 Q38268088-0C003E62-E252-468E-902E-7DE59F099201

P2860

VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.

Item

http://www.wikidata.org/entity/Q39078119

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@en

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@nl

type

Item

label

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@en

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@nl

prefLabel

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@en

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@nl

P1476

VEGF depletion enhances bcr-ab ...... chronic myelogenous leukemia.

@en

P2093

Jia Fei

http://www.w3.org/2001/XMLSchema#string

Maoxiao Feng

http://www.w3.org/2001/XMLSchema#string

Xiaochuang Luo

http://www.w3.org/2001/XMLSchema#string

Xuejiao Zhu

http://www.w3.org/2001/XMLSchema#string

Yuan Zhang

http://www.w3.org/2001/XMLSchema#string

Yumin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

Expanding the use of arsenic trioxide: leukemias and beyond.

Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide

P304

334-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/1607845413Y.0000000083

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24129092

http://www.w3.org/2001/XMLSchema#string

VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.

about

P2860

P2860

VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698